Monday, 12 December 2016

Procedure for preparation & control of site master file

1.0
PURPOSE
To lay down systematic procedure for the preparation of Site Master File, this briefs about the facility To lay down systematic procedure for the preparation of Site Master File, this briefs about the facility.

2.0
SCOPE
This method is applicable to the preparation of Site Master File.
3.0
RESPONSIBILITY
QA Officer/Executive.
4.0
ACCOUNTABILITY
Head Quality Assurance.
5.0

5.1


5.2


5.3

5.4








5.5

5.6









5.7

5.7.1

5.7.2

5.7.3

5.7.4

5.7.5

5.7.6

5.7.7


5.7.8


5.7.9

5.7.10

5.7.11

5.7.12

5.7.13

5.7.14


5.7.15

5.7.16

5.8

5.8.1

5.8.2

5.8.3

5.8.4

5.8.5

5.9


5.9.1

5.9.2

5.9.3


5.9.4

5.9.5
5.9.6

5.9.7


5.9.8

5.9.9

5.9.10

5.9.11



5.9.12


5.10

5.10.1


5.10.2

5.11

5.11.1

5.11.2


5.11.3

5.11.4
5.11.5

5.12

5.12.1

5.12.2

5.12.3


5.12.4


5.13

5.13.1

5.14

5.14.1

5.14.2

5.15


PROCEDURE

Site master file shall be prepared as a concise package of information on the manufacturing site & in particular the production blocks for which the site masters file shall be prepared.

Site master file shall be prepared based on the contents described in World Health Organization (WHO) technical series number 823. The contents are listed in Annexure – I.

Describe each content point briefly with the help of concerned department.

Site master file shall be numbered as follows;
        SMF / YYYY – YY/ NN
        SMF    : Site Master File
        YYYY: The current calendar year.
          -         : Separator.
         YY    : The last two characters of the next year.
           /        :  Separator.
          NN: The revision number starting from 00.

The SMF shall be prepared / Reviewed once a Year.

Any required subsequent changes shall be made as “Amendments” to the specific Site Master File.
The Numbering system for the Amendments shall be as follows:
     SMF / YYYY / NN/01
     SMF    : Site Master File
     YYYY: The current calendar year.
          /      : Separator.
         /       :  Separator.
          NN : The revision number starting from 00.
    01 indicate Amendments No in ascending order starting with 01 .

The Site Master File shall be prepared under the following sub headings:

General information.

Brief information of the firm, which includes name & complete address of the firm.

Particular information relevant to understand the manufacturing operation.

Pharmaceutical manufacturing activity as licensed by the competent authorities.

Any other manufacturing activities carried out on the site.

Name & address of the site & any other communication detail, with 24 hrs telephone number.

Type of actual product manufactured on the site & the information about toxic or hazardous substances handled,  
 mentioning the way they are manufactured.

Short description of the site starting the size, location, immediate environment and other manufacturing activities on the site. 

Number of employees engaged in the production. Quality control, storage & distribution.

 Brief about the outside scientific, analytical or technical assistance in relation to manufacture & analysis.

 Description of the Quality Management System of the Firm responsible for manufacturing.
 
Quality policy.

 Responsibilities of Quality Assurance.

 Elements of QA system like organization structure, responsibilities, procedures, process specification, test
 Methods &other quality related data collection.

 Self – infection or audits by external organization undertaken.

Review of batch documentation and release of batch.

 Personnel Requirement:

 Organization chart showing the arrangements for quality assurance, including production and quality control.

 Qualification, experience and responsibilities of the key personnel.

Training arrangement for the basis and the in – service and maintenance of records.

Health requirement of the personnel engaged in production.

Personnel hygiene requirements, including clothing.

Premises and equipment:

Premises
Simple plan or description of manufacturing area with the indication of scale.

Nature of construction and finishes.

Brief description of ventilation systems. More details should be given for critical with potential risks of airborne  
Contamination (schematic drawings of the system are desirable).

Classification of the room used for the manufacture of production.

Special areas for the handling of highly toxic, hazardous and sensitizing materials.
Description of water system (schematic drawing of the system are desirable) including sanitation.

Maintenance (description of planned preventive maintenance programmes and recording system).

Equipment
Description of major production and laboratory equipment.

Maintenance (description of planned preventative maintenance programmes and recording system).

Qualification and calibration, including recording system.

Arrangements for computerized systems validation.

Sanitation

Availability of written validated specifications and procedures for cleaning manufacturing and equipment. Change of cleaning agent at frequencies.

Documentation:

Arrangements for the preparation, revision and distribution of necessary documentation  for manufacture of the
Product.

Documentation related to product quality (e.g. microbiological controls on air and water).

Production:

Brief description on the existing production operations by means of flow chart specifying important parameters.

Handling of starting materials, packing materials, bulk and finished products, including sampling, testing, release and storage.

 Brief description of general policy for process validation.

 In – process checks and records.
Records of key parameters.

Quality Control:

Description of the Quality Control system and of the activities of the Quality Control Department.

Procedure for the release of finished products.

Quality control activity like analytical testing, packing component testing, biological and microbiological testing.

Role of QC in the arrangements for the preparation, revision and distribution of documents in particular those for specification test methods and release criteria.

Contract manufacture and analysis:

Description of the way in which the GMP compliance of the contract acceptor is assessed.

Distribution, Complaints and Product recall:

Arrangements and recording system for distribution.

Arrangements for the handing of market complaints and product recall.

 Self inspection:
Short description of the self inspection system.

 6.0
REFERENCES     
WHO technical series number 823
7.0
ANNEXURES

Annexure No.
Title of Annexure
Format No.
Annexure I
                  SPECIMEN FORMAT FOR SMF
QA/008/F01-01

8.0
ABBREVIATIONS
Abbreviations
Full Forms
SOP
Standard Operating Procedure
QA
Quality Assurance
GMP
Good manufacturing practices
QC
Quality Control
SMF
Site Master File
WHO
World Health Organization


9.0
DISTRIBUTION
Master Copy
Head Quality Assurance Department

Controlled office Copy No. 1
Head Quality Assurance Deptt.


10.0

REVISION HISTORY
S.No.
Revision No.
Effective Date
Reason for Revision
Details of Change
Authorized By
(sign & Date)


















                                   


TABLE OF CONTENTS
PARTICULARS
PAGE No.
Table of Content

General Information

Manufacturing Site & Manufacturing Activities.

Quality Management System /Quality Policy

Responsibility of Key Personnel

Qualification & Experience of Technical Staff

Health requirement, Personnel Hygiene & Training

Premises and  Ventilation System

Potable water & Water Purification System

Effluent Treatment Plant.

Preventive Programme For Premises

Plant and Machinery Installed and Preventive Maintenance

Qualification and Calibration

Sanitation

Documentation

Policy of Process Validation & Production Activity Flow.

Handling of Rejected Materials.

Quality Control Activity

Distribution, Complaints and Product Recall

Self Inspection

List of Annexure

Annexure I

SPECIMEN FORMAT FOR SMF

No comments:

Post a Comment

Tablet coating and their related questions

Tablet coating and their related questions: What is Tablet coating ?   Tablet coating  is one of the oldest pharmaceutical pro...